Long-Term Outcomes of 25-Gauge Pars-Plana Vitrectomy in Diabetic Tractional Retinal Detachment

The human eye is a delicate organ, and for millions of people living with diabetes, its most vulnerable part is the retina, the light-sensitive tissue at the back that acts like the film in a camera. Over time, high blood sugar can damage the tiny blood vessels within this tissue, causing them to leak or grow abnormally. In severe cases, this damage leads to a condition called proliferative diabetic retinopathy, where scar tissue forms and begins to pull on the retina. When this pulling becomes strong enough, it can lift the retina away from the back of the eye, much like wallpaper peeling off a damp wall. This separation, known as a tractional retinal detachment, cuts off the retina from its blood supply and can lead to permanent blindness if not treated.

To fix this, surgeons perform a procedure called a pars plana vitrectomy. In this operation, the surgeon makes tiny openings in the white part of the eye to remove the gel that fills the center of the eye, along with the scar tissue that is pulling the retina. Once the scar tissue is gone, the retina can settle back into place. For years, the standard tools for this surgery were relatively thick, but in recent decades, surgeons have switched to much thinner instruments, specifically 25-gauge tools, which are about the width of a human hair. These smaller tools promise less trauma to the eye and a quicker recovery, but until now, there has been a lack of large-scale, long-term data confirming how well they work for the most severe cases of diabetic retinal detachment.

A team of researchers at the Adolphe de Rothschild Foundation Hospital in Paris set out to fill this gap by looking back at the records of 116 patients who had undergone this specific surgery between 2017 and 2023. They focused on 124 eyes that had been treated for tractional retinal detachment using the 25-gauge technique. The researchers were careful to exclude cases where the view was blocked by heavy bleeding or where the eye had already been operated on before, ensuring they were studying the primary repair of the detachment itself. Their goal was to see not just if the retina stayed attached, but also how the patients' vision changed over time, tracking them for an average of nearly two years after the operation.

The results of this long-term look were encouraging. The surgery was highly effective at reattaching the retina. In more than nine out of ten eyes, the retina was successfully put back in place after the first operation. When a few eyes needed a second or third surgery to fix complications or re-detachments, the final success rate climbed to nearly 99 percent. This high rate of anatomical success suggests that the delicate 25-gauge instruments are capable of handling the complex task of removing tough scar tissue without causing the retina to fall off again. The researchers also noted that the complications associated with the surgery were relatively rare. While some patients experienced bleeding inside the eye or a temporary rise in eye pressure, these issues were manageable, and serious problems like infection were not observed in this group.

Perhaps even more important than the physical reattachment was the impact on the patients' sight. Before the surgery, 45.2% of the eyes in the study were considered legally blind, meaning their vision was so poor they could not be classified as having moderate impairment, while 37% had moderate-to-severe visual impairment. After the surgery, the number of legally blind patients dropped significantly, falling to less than one-fifth of the group. While the average vision improved for everyone, the study highlighted a crucial factor: the timing of the operation. Patients whose retinas were still attached to the back of the eye at the moment of surgery, specifically the central part known as the macula, ended up with much better vision than those whose maculas had already detached. For those whose central vision was already lost due to the detachment, the surgery still offered a substantial improvement, often lifting them out of the deepest levels of blindness, but the final vision remained limited by the damage that had already occurred.

The study confirms that using these fine, 25-gauge tools is a safe and powerful way to treat this severe form of diabetic eye disease. It reinforces the idea that while modern surgery can repair the physical structure of the eye and restore a significant amount of function, the best outcomes depend on acting before the damage becomes irreversible. By intervening early, before the central part of the retina is pulled away, surgeons can offer patients the best chance of preserving their ability to see the world clearly. This large collection of real-world data provides strong evidence that the shift to smaller surgical instruments has been a positive step forward for patients facing the threat of blindness from diabetes.